The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox
NF Voelkel, J Gomez-Arroyo - American journal of respiratory cell …, 2014 - atsjournals.org
Pulmonary arterial hypertension (PAH) is characterized by dysfunctional angiogenesis
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
[PDF][PDF] TRANSLATIONAL REVIEW
American Journal of Respiratory Cell and Molecular …, 2014 - researchgate.net
Pulmonary arterial hypertension (PAH) is characterized by dysfunctional angiogenesis
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
The Role of Vascular Endothelial Growth Factor in Pulmonary Arterial Hypertension: The Angiogenesis Paradox
NF Voelkel, J Gomez-Arroyo - American Journal of Respiratory …, 2014 - search.proquest.com
Pulmonary arterial hypertension (PAH) is characterized by dysfunctional angiogenesis
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
[引用][C] The Role of Vascular Endothelial Growth Factor in Pulmonary Arterial Hypertension. The Angiogenesis Paradox
NF Voelkel, J Gomez-Arroyo - American Journal of Respiratory Cell and …, 2014 - cir.nii.ac.jp
The Role of Vascular Endothelial Growth Factor in Pulmonary Arterial Hypertension. The
Angiogenesis Paradox | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Angiogenesis Paradox | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.
NF Voelkel, J Gomez-Arroyo - American Journal of Respiratory Cell …, 2014 - europepmc.org
Pulmonary arterial hypertension (PAH) is characterized by dysfunctional angiogenesis
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox
NF Voelkel, J Gomez-Arroyo - American journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is characterized by dysfunctional angiogenesis
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …
leading to lung vessel obliteration. PAH is widely considered a proangiogenic disease; …